Deutsche Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.3M | Buy |
141,601
+12,478
| +10% | +$1.21M | ﹤0.01% | 990 |
|
|
2025
Q4 | $13.8M | Buy |
129,123
+12,381
| +11% | +$1.31M | ﹤0.01% | 986 |
|
|
2025
Q3 | $11.8M | Buy |
116,742
+79,963
| +217% | +$7.42M | ﹤0.01% | 1004 |
|
|
2025
Q2 | $2.32M | Sell |
36,779
-7,000
| -16% | -$429K | ﹤0.01% | 1613 |
|
|
2025
Q1 | $2.32M | Sell |
43,779
-4,966
| -10% | -$276K | ﹤0.01% | 1653 |
|
|
2024
Q4 | $2.73M | Buy |
48,745
+15,481
| +47% | +$855K | ﹤0.01% | 1657 |
|
|
2024
Q3 | $1.74M | Buy |
33,264
+7,204
| +28% | +$345K | ﹤0.01% | 1841 |
|
|
2024
Q2 | $1.07M | Sell |
26,060
-2,099
| -7% | -$83.8K | ﹤0.01% | 1956 |
|
|
2024
Q1 | $1.22M | Buy |
28,159
+1,111
| +4% | +$48.6K | ﹤0.01% | 1914 |
|
|
2023
Q4 | $1.24M | Sell |
27,048
-404
| -1% | -$12.7K | ﹤0.01% | 1902 |
|
|
2023
Q3 | $629K | Buy |
27,452
+3,227
| +13% | +$72.3K | ﹤0.01% | 2021 |
|
|
2023
Q2 | $399K | Buy |
24,225
+18,579
| +329% | +$335K | ﹤0.01% | 2482 |
|
|
2023
Q1 | $101K | Hold |
5,646
| – | – | ﹤0.01% | 3323 |
|
|
2022
Q4 | $164K | Buy |
+5,646
| New | +$145K | ﹤0.01% | 3078 |
|
|
2022
Q2 | – | Sell |
-227,114
| Closed | -$2.62M | – | 4297 |
|
|
2022
Q1 | $2.62M | Buy |
227,114
+200,360
| +749% | +$1.76M | ﹤0.01% | 1737 |
|
|
2021
Q4 | $267K | Buy |
26,754
+115
| +0.4% | +$1.29K | ﹤0.01% | 3219 |
|
|
2021
Q3 | $348K | Sell |
26,639
-3,237
| -11% | -$49.4K | ﹤0.01% | 3260 |
|
|
2021
Q2 | $585K | Sell |
29,876
-9,353
| -24% | -$194K | ﹤0.01% | 3119 |
|
|
2021
Q1 | $834K | Buy |
39,229
+13,171
| +51% | +$382K | ﹤0.01% | 2783 |
|
|
2020
Q4 | $775K | Buy |
26,058
+6,730
| +35% | +$171K | ﹤0.01% | 2625 |
|
|
2020
Q3 | $419K | Buy |
19,328
+1,316
| +7% | +$30.2K | ﹤0.01% | 2768 |
|
|
2020
Q2 | $401K | Buy |
18,012
+7,571
| +73% | +$148K | ﹤0.01% | 2769 |
|
|
2020
Q1 | $159K | Sell |
10,441
-11,178
| -52% | -$200K | ﹤0.01% | 3047 |
|
|
2019
Q4 | $495K | Buy |
21,619
+14,914
| +222% | +$331K | ﹤0.01% | 2721 |
|
|
2019
Q3 | $144K | Sell |
6,705
-6,208
| -48% | -$133K | ﹤0.01% | 3380 |
|
|
2019
Q2 | $282K | Buy |
12,913
+3,428
| +36% | +$86.6K | ﹤0.01% | 3636 |
|
|
2019
Q1 | $258K | Buy |
9,485
+4,616
| +95% | +$133K | ﹤0.01% | 3858 |
|
|
2018
Q4 | $130K | Sell |
4,869
-109,684
| -96% | -$3.03M | ﹤0.01% | 4095 |
|
|
2018
Q3 | $3.34M | Buy |
114,553
+61,358
| +115% | +$1.94M | ﹤0.01% | 2503 |
|
|
2018
Q2 | $1.66M | Buy |
53,195
+42,547
| +400% | +$1.16M | ﹤0.01% | 3088 |
|
|
2018
Q1 | $211K | Sell |
10,648
-8,085
| -43% | -$215K | ﹤0.01% | 4170 |
|
|
2017
Q4 | $542K | Buy |
+18,733
| New | +$495K | ﹤0.01% | 3552 |
|
Other funds holding RYTM
RCM
BBA
VPM
VCM
PA
Deutsche Bank's RYTM Position: Q1 2026 in Review
Deutsche Bank increased its Rhythm Pharmaceuticals (RYTM) stake by 9.7% in Q1 2026, buying an estimated $1.21M and bringing the position to 141,601 shares worth $12.3M. The position accounts for ﹤0.01% of the portfolio, ranked #990.
Deutsche Bank first reported a position in RYTM in Q4 2017 and has held it in 32 quarters since. The position peaked at $13.8M in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.
- Deutsche Bank held 141,601 shares of Rhythm Pharmaceuticals worth $12.3M as of Q1 2026.
- Deutsche Bank bought 12,478 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $1.21M.
- Rhythm Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #990 holding.
- Deutsche Bank first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 32 quarters since.
- Deutsche Bank's Rhythm Pharmaceuticals position peaked at $13.8M in Q4 2025.
- 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.